Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial - cnbc.com
Source:CNBC
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Related Articles
Pennsylvania sues Character.AI over claims chatbot posed as doctor - NPR
State officials allege a Character.AI bot claimed to be a licensed psychiatrist and provided a fake …
Why Wall Street is unhappy with Trump's pick for Fed chair - Axios
Investors are getting their least favorite thing: uncertainty.
Discord is delaying its global age verification rollout - The Verge
Discord will delay a planned global rollout of age verification for accounts accessing restricted …
Oman Evacuates Ships From Oil Terminal in Precautionary Move - Bloomberg.com
Oman’s key oil export terminal was evacuated and two crude tankers were hit in Iraqi waters, as …